Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy.

A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy. Oncogene. 2003 Apr 10; 22(14):2065-72.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.